Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Bispecific and tetravalent CD137 and FAP molecules for the treatment of cancer

Bispecific and tetravalent CD137 and FAP molecules for the treatment of cancer

US Patent 12146000 · Granted Nov 19, 2024

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anti-C3 antibodies and antigen-binding fragments thereof and their uses for trea2025
Anti-PD-1 antibodies2025
Binding molecules for BCMA and CD32025
Binding molecules for BCMA and CD32025
Tri-specific binding molecules2025
Multi-specific binding proteins for cancer treatment2024
Multi-specific binding proteins for cancer treatment2024
Bispecific anti-VEGF and anti-TrkB binding molecules for the treatment of eye di2024
Production of heteromultimeric proteins using mammalian cells2024
Humanized and affinity matured antibodies to FcRH5 and methods of use2024
Fc variants and methods for their production2024
Compound targeting IL-23A and B-cell activating factor (BAFF) and uses thereof2024